NCT02138526View on ClinicalTrials.gov

Pazopanib Tolerability When Given With Food

PHASE1CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Cancer
Interventions
DRUG

pazopanib

pazopanib 800mg OD without food

OTHER

continental breakfast

pazopanib 600mg OD with food

Trial Locations (1)

6500 HB

RadboudUMC, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT02138526 - Pazopanib Tolerability When Given With Food | Biotech Hunter | Biotech Hunter